Antitumor activity of CEP-751 (KT-6587) on human neuroblastoma and medulloblastoma xenografts.

Audrey E. Evans(Purdue University West Lafayette), Garrett M. Brodeur(Children's Hospital of Philadelphia), Darrell J. Yamashiro(Morgan Stanley Children's Hospital), Craig A. Dionne, Anna Marie Camoratto(Avalon Pharma (United States)), Kristin D. Kisselbach(Teva Pharmaceuticals (Czechia)), Naohiko Ikegaki(University of Illinois Chicago)
PubMed
November 1, 1999
Cited by 87

Related Papers

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
|Journal of Clinical Oncology|1993|2.3k
A proposed staging for children with neuroblastoma.Children's cancer study group A
|Cancer|1971|953
Treatment of Wilms' tumor. Results of the third national Wilms' tumor study
|Cancer|1989|685
International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.
|Journal of Clinical Oncology|1988|608
The treatment of medulloblastoma
|Journal of neurosurgery|1990|583